Ancora Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.5K | Sell |
60
-1
| -2% | -$525 | ﹤0.01% | 1107 |
|
|
2025
Q1 | $38.7K | Sell |
61
-9
| -13% | -$5.71K | ﹤0.01% | 1047 |
|
|
2024
Q4 | $49.9K | Sell |
70
-86
| -55% | -$61.3K | ﹤0.01% | 987 |
|
|
2024
Q3 | $164K | Buy |
156
+1
| +0.6% | +$1.05K | ﹤0.01% | 720 |
|
|
2024
Q2 | $163K | Hold |
155
| – | – | ﹤0.01% | 690 |
|
|
2024
Q1 | $149K | Hold |
155
| – | – | ﹤0.01% | 722 |
|
|
2023
Q4 | $136K | Sell |
155
-37
| -19% | -$32.5K | ﹤0.01% | 721 |
|
|
2023
Q3 | $158K | Sell |
192
-13
| -6% | -$10.7K | ﹤0.01% | 684 |
|
|
2023
Q2 | $147K | Buy |
205
+8
| +4% | +$5.75K | ﹤0.01% | 697 |
|
|
2023
Q1 | $162K | Buy |
197
+40
| +25% | +$32.9K | ﹤0.01% | 675 |
|
|
2022
Q4 | $113K | Buy |
157
+2
| +1% | +$1.44K | ﹤0.01% | 781 |
|
|
2022
Q3 | $107K | Hold |
155
| – | – | ﹤0.01% | 855 |
|
|
2022
Q2 | $92K | Sell |
155
-2
| -1% | -$1.19K | ﹤0.01% | 968 |
|
|
2022
Q1 | $110K | Sell |
157
-17
| -10% | -$11.9K | ﹤0.01% | 975 |
|
|
2021
Q4 | $110K | Buy |
174
+17
| +11% | +$10.7K | ﹤0.01% | 985 |
|
|
2021
Q3 | $95K | Sell |
157
-12
| -7% | -$7.26K | ﹤0.01% | 980 |
|
|
2021
Q2 | $94K | Sell |
169
-95
| -36% | -$52.8K | ﹤0.01% | 918 |
|
|
2021
Q1 | $125K | Hold |
264
| – | – | ﹤0.01% | 801 |
|
|
2020
Q4 | $128K | Hold |
264
| – | – | ﹤0.01% | 685 |
|
|
2020
Q3 | $148K | Buy |
264
+14
| +6% | +$7.85K | 0.01% | 635 |
|
|
2020
Q2 | $156K | Buy |
250
+10
| +4% | +$6.24K | 0.01% | 611 |
|
|
2020
Q1 | $117K | Buy |
240
+50
| +26% | +$24.4K | 0.01% | 720 |
|
|
2019
Q4 | $71K | Buy |
+190
| New | +$71K | ﹤0.01% | 814 |
|